3.06
0.16%
0.005
Schlusskurs vom Vortag:
$3.055
Offen:
$3.03
24-Stunden-Volumen:
527.88K
Relative Volume:
0.61
Marktkapitalisierung:
$155.52M
Einnahmen:
$293.47M
Nettoeinkommen (Verlust:
$-274.55M
KGV:
-0.4865
EPS:
-6.29
Netto-Cashflow:
$-27.43M
1W Leistung:
-21.13%
1M Leistung:
-17.52%
6M Leistung:
-63.09%
1J Leistung:
-59.95%
Cardlytics Inc Stock (CDLX) Company Profile
Firmenname
Cardlytics Inc
Sektor
Branche
Telefon
888-798-5802
Adresse
675 PONCE DE LEON AVENUE, NE, ATLANTA, GA
Vergleichen Sie CDLX mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
CDLX
Cardlytics Inc
|
3.06 | 155.52M | 293.47M | -274.55M | -27.43M | -6.29 |
OMC
Omnicom Group Inc
|
86.79 | 17.00B | 15.43B | 1.37B | 1.50B | 7.32 |
WPP
Wpp Plc Adr
|
47.48 | 10.24B | 18.59B | 256.66M | 1.13B | 1.1736 |
IPG
Interpublic Group Of Cos Inc
|
28.67 | 9.95B | 10.86B | 808.20M | 922.50M | 2.12 |
MGNI
Magnite Inc
|
17.20 | 2.42B | 649.22M | -5.40M | 158.90M | -0.11 |
ZD
Ziff Davis Inc
|
53.89 | 2.30B | 1.37B | 59.76M | 173.37M | 1.21 |
Cardlytics Inc Stock (CDLX) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-10-11 | Eingeleitet | Evercore ISI | In-line |
2024-08-16 | Herabstufung | Northland Capital | Outperform → Market Perform |
2024-08-15 | Herabstufung | BofA Securities | Neutral → Underperform |
2024-08-08 | Herabstufung | Craig Hallum | Buy → Hold |
2024-08-08 | Herabstufung | Lake Street | Buy → Hold |
2024-08-08 | Herabstufung | Needham | Buy → Hold |
2024-06-20 | Fortgesetzt | BofA Securities | Neutral |
2024-06-18 | Eingeleitet | Northland Capital | Outperform |
2024-03-15 | Hochstufung | Craig Hallum | Hold → Buy |
2023-11-29 | Eingeleitet | Lake Street | Buy |
2022-09-08 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
2022-07-14 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
2022-07-13 | Herabstufung | BofA Securities | Neutral → Underperform |
2022-07-12 | Herabstufung | Craig Hallum | Buy → Hold |
2022-04-05 | Fortgesetzt | Wells Fargo | Overweight |
2021-06-18 | Eingeleitet | Needham | Buy |
2021-04-15 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
2021-04-14 | Hochstufung | Craig Hallum | Hold → Buy |
2021-03-05 | Hochstufung | BofA Securities | Underperform → Neutral |
2021-01-14 | Herabstufung | William Blair | Outperform → Mkt Perform |
2020-08-28 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
2020-04-21 | Herabstufung | BofA/Merrill | Buy → Underperform |
2020-03-04 | Herabstufung | Craig Hallum | Buy → Hold |
2020-01-15 | Herabstufung | Raymond James | Outperform → Mkt Perform |
2019-12-02 | Eingeleitet | Craig Hallum | Buy |
2019-11-14 | Herabstufung | JP Morgan | Overweight → Neutral |
2019-08-09 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
2019-07-24 | Bestätigt | BofA/Merrill | Buy |
2019-07-01 | Eingeleitet | William Blair | Outperform |
2019-01-15 | Hochstufung | BofA/Merrill | Neutral → Buy |
Alle ansehen
Cardlytics Inc Aktie (CDLX) Neueste Nachrichten
Cardlytics, Inc. (NASDAQ:CDLX) Receives $6.92 Consensus Price Target from Analysts - Defense World
Cardlytics, Inc. (NASDAQ:CDLX) Insider Sells $10,772.63 in Stock - MarketBeat
CDLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cardlytics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Business Wire
CDLX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cardlytics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
Class Action Filed Against Cardlytics, Inc. (CDLX)March 25, 2 - GuruFocus.com
Cardlytics (CDLX) Faces Investor Lawsuit Over Growth Projections – Hagens Berman - GlobeNewswire
Analysts Set Cardlytics, Inc. (NASDAQ:CDLX) PT at $6.92 - MarketBeat
CDLX Investors Have Opportunity to Lead Cardlytics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Marketscreener.com
Cardlytics, Inc. Class Action Alert: Wolf Haldenstein Adler - GlobeNewswire
CDLX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cardlytics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
CDLX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cardlytics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cardlytics - GlobeNewswire
CARDLYTICS ALERT: Bragar Eagel & Squire, P.C. Announces - GlobeNewswire
Shareholder Notice: Robbins LLP Informs Stockholders of the Cardlytics, Inc. Class Action - PR Newswire
CDLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
CDLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cardlytics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
Great week for Cardlytics, Inc. (NASDAQ:CDLX) institutional investors after losing 46% over the previous year - Simply Wall St
Advertising Platform's Changes Hurt Investors, Suit Says - Law360
CDLX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cardlytics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
2025-01-27 | CDLX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cardlytics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:CDLX | Press Release - Stockhouse Publishing
Rosen Law Firm Urges Cardlytics, Inc. (NASDAQ: CDLX) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights - Business Wire
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cardlytics - Markets Insider
Cardlytics CEO Amit Gupta sells common stock for $59,427 - MSN
Insider Selling: Cardlytics, Inc. (NASDAQ:CDLX) CEO Sells 15,160 Shares of Stock - MarketBeat
Cardlytics CEO Amit Gupta sells common stock for $59,427 By Investing.com - Investing.com Canada
Major Stock Plunge Alert! Are You Affected? - Mi Valle
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cardlytics - Business Wire
Cardlytics, Inc. Announcement: If You Have Suffered Losses - GlobeNewswire
Cardlytics, Inc. (NASDAQ:CDLX) Shares Acquired by Barclays PLC - Defense World
CDLX Investor News: Rosen Law Firm Encourages Cardlytics, Inc. Investors to Inquire About Securities Class Action InvestigationCDLX - The Eastern Progress Online
ROSEN, LEADING INVESTOR COUNSEL, Encourages Cardlytics, - GlobeNewswire
Parsons Stock Gains 49% in a Year: What Should Investors Do Now? - MSN
Cardlytics (NASDAQ:CDLX) Earns “Hold” Rating from Needham & Company LLC - Defense World
Cardlytics (NASDAQ:CDLX) Earns "Hold" Rating from Needham & Company LLC - MarketBeat
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Cardlytics, Inc. - GlobeNewswire
CDLX Investors Have Opportunity to Join Cardlytics, Inc. Securities Fraud Investigation with the Schall Law Firm - PR Newswire
Securities Fraud Investigation Into Cardlytics, Inc. (CDLX) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - Business Wire
Cardlytics, Inc. Company Investigated by the Portnoy Law Firm - GlobeNewswire
Rosen Law Firm Encourages Cardlytics, Inc. Investors with Losses in Excess of $100K to Inquire About Securities Class Action Investigation – CDLX - Business Wire
Cardlytics stock plunges to 52-week low of $2.89 amid market challenges - Investing.com Australia
Cardlytics stock plunges to 52-week low of $2.89 amid market challenges By Investing.com - Investing.com South Africa
At US$3.35, Is It Time To Put Cardlytics, Inc. (NASDAQ:CDLX) On Your Watch List? - Simply Wall St
With 49% stake, Cardlytics, Inc. (NASDAQ:CDLX) seems to have captured institutional investors' interest - Yahoo Finance
Brokerages Set Cardlytics, Inc. (NASDAQ:CDLX) Price Target at $6.92 - Defense World
Geode Capital Management LLC Purchases 73,484 Shares of Cardlytics, Inc. (NASDAQ:CDLX) - Defense World
Amit Gupta Sells 5,964 Shares of Cardlytics, Inc. (NASDAQ:CDLX) Stock - MarketBeat
Finanzdaten der Cardlytics Inc-Aktie (CDLX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):